Clinic
Coosa Family Care LLC
Coosa Family Care LLC was paid $698K by Medicaid between Oct 2019 and Dec 2024, across 17 billing codes. Its largest line is 87633, Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets — 38% of everything it billed.
33Billing provider infoCOOSA FAMILY CARE LLC
RAINBOW CITY, AL 35906
RAINBOW CITY, AL 35906
33aNPI1578113221assigned 09/15/2019
33bProvider typePrimary Care Clinic/Center
28Total paid$698K
24GClaims9,088
24DCodes billed17
24AFirst – last monthOct 2019 – Dec 2024
Compared with peers
Next to other Primary Care Clinic/Center providers in Alabama
Rank by total paid#15 of 75
Median peer was paid$56K
This provider vs. median12×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 16 | $311.60 | |
| 2020 | 42 | $318.80 | |
| 2021 | 183 | $3K | |
| 2022 | 478 | $24K | |
| 2023 | 1,124 | $30K | |
| 2024incomplete | 7,245 | $641K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 38% | 1,908 | 1,551 | $262K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 31% | 1,262 | 1,165 | $218K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 16% | 1,852 | 1,384 | $114K |
| 87581 | 5.0% | 1,402 | 1,312 | $35K | |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 3.3% | 677 | 478 | $23K |
| 87631 | 2.0% | 225 | 217 | $14K | |
| 87640 | 1.2% | 398 | 381 | $8K | |
| 87498 | 1.0% | 336 | 326 | $7K | |
| 86684 | <1% | 336 | 327 | $6K | |
| 86615 | <1% | 336 | 326 | $5K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 111 | 107 | $4K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 27 | 26 | $1K |
5 more codes
| 87486 | <1% | 58 | $1K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 16 | $311.60 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 101 | $262.73 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 20 | $29.31 |
| 36415 | Collection of venous blood by venipuncture | <1% | 23 | $22.40 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHOLDER, KRISTOPHER (OWNER/MANAGER)